Quick links

Press Releases

Search: From date To date
January 24, 2012 InSightec submits Pre Market Application (PMA) for FDA approval of ExAblate for treatment of painful bone metastases
January 3, 2012 Enrollment in first MRgFUS Essential Tremor feasibility trial completed
November 27, 2011 NICE issues updated guidance for MR guided Focused Ultrasound for uterine fibroids
July 13, 2011 23 Patients with Organ Confined Low Risk Prostate Cancer Have Been Treated In Clinical Trials Using The ExAblate® Non-Invasive Prostate Cancer System
September 29, 2010 InSightec Launches ExAblate® One and ExAblate® OR Systems at CIRSE 2010
August 31, 2010 InSightec Treats First Prostate Cancer Patients in Clinical Trials

June 23, 2010 ExAblate® Receives European CE Mark for Treatment of Adenomyosis
April 22, 2010 Innovative technology could transform women’s health across Europe
January 26, 2010 InSightec Announces India Distribution Agreement with Kirloskar
Kirloskar to Distribute ExAblate® 2000 Non-Invasive Magnetic Resonance-guided Focused Ultrasound Systems Throughout the Country
January 13, 2010 First Non-Invasive Technology for Treatment of Uterine Fibroids Awarded MHLW Approval in Japan
November 11, 2009 Non-Invasive Uterine Fibroid Treatment with ExAblate® Shows Significantly Fewer Complications and Faster Recovery than Hysterectomy

Three studies supporting use of ExAblate and Magnetic Resonance-guided Focused Ultrasound (MRgFUS) Published in Ultrasound in Obstetrics and Gynecology

July 14, 2009 A Swiss Team Uses Transcranial MR-Guided Focused Ultrasound to Treat Patients with Functional Brain Disorders
April 7, 2009 FDA APPROVES LABEL CHANGE FOR NON-INVASIVE FIBROID TREATMENT
March 19, 2009 InSightec Ltd. announces $15 Million Investment Round
December 16, 2008 MyCancerPain.org Launched as Resource for Patients with Painful Bone Metastases
December 2, 2008 New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound To Be A Potentially Safe‚ Effective Pain-Relieving Treatment for Bone Metastases
July 21, 2008 First U.S. Patient Undergoes Non-Invasive Magnetic Resonance-Guided Focused Ultrasound Procedure to Relieve Pain from Bone Metastases
May 28, 2008 FDA Clears ExAblate Fertility Enhancement Study in Women with Uterine Fibroids
April 21, 2008 InSightec to Exhibit Non-Invasive Treatment for Uterine Fibroids at 5th Annual World Health Care Congress
December 17, 2007 InSightec Starts Pivotal Study of ExAblate® to Treat Pain Caused by Bone Metastases
 
1 2
Next Next